Clinical Diabetology最新文献

筛选
英文 中文
The Effect of Training About Sleep Hygiene on HbA1c Levels of Type 2 Diabetes Mellitus Patients: A Randomized Controlled Trial 睡眠卫生训练对2型糖尿病患者HbA1c水平的影响:一项随机对照试验
IF 0.7
Clinical Diabetology Pub Date : 2022-10-31 DOI: 10.5603/dk.a2022.0046
Ayşenur Gündüz, S. Görpelioğlu, C. Emiroğlu, Özlem Suvak, C. Aypak
{"title":"The Effect of Training About Sleep Hygiene on HbA1c Levels of Type 2 Diabetes Mellitus Patients: A Randomized Controlled Trial","authors":"Ayşenur Gündüz, S. Görpelioğlu, C. Emiroğlu, Özlem Suvak, C. Aypak","doi":"10.5603/dk.a2022.0046","DOIUrl":"https://doi.org/10.5603/dk.a2022.0046","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":"28 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82619652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Relationship between Thyroid Hormones, Metabolic Syndrome and HOMA-IR in People with Obesity or Overweight 肥胖或超重人群甲状腺激素、代谢综合征与HOMA-IR的关系
IF 0.7
Clinical Diabetology Pub Date : 2022-10-31 DOI: 10.5603/dk.a2022.0043
C. Emiroğlu, Çağla Özdemi̇r, S. Görpelioğlu, C. Aypak
{"title":"The Relationship between Thyroid Hormones, Metabolic Syndrome and HOMA-IR in People with Obesity or Overweight","authors":"C. Emiroğlu, Çağla Özdemi̇r, S. Görpelioğlu, C. Aypak","doi":"10.5603/dk.a2022.0043","DOIUrl":"https://doi.org/10.5603/dk.a2022.0043","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":"17 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87287358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Saroglitazar: One Molecule for Managing Two Diseases, Type 2 Diabetes and Hypertriglyceridemia Saroglitazar:一种治疗2型糖尿病和高甘油三酯血症的分子
IF 0.7
Clinical Diabetology Pub Date : 2022-10-31 DOI: 10.5603/dk.a2022.0048
D. Hasnani, V. Chavda
{"title":"Saroglitazar: One Molecule for Managing Two Diseases, Type 2 Diabetes and Hypertriglyceridemia","authors":"D. Hasnani, V. Chavda","doi":"10.5603/dk.a2022.0048","DOIUrl":"https://doi.org/10.5603/dk.a2022.0048","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":"1 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88811690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between TG/HDL-C Ratio and TyG Index with Chronic Inflammation in People with Prediabetes: A Cross-Sectional Study TG/HDL-C比值和TyG指数与糖尿病前期慢性炎症的关系:一项横断面研究
IF 0.7
Clinical Diabetology Pub Date : 2022-10-31 DOI: 10.5603/dk.a2022.0047
Rizal Fahly, Fabiola M. S. Adam, H. Rasyid, A. Aman, S. Bakri, Idar Mappangara, A. A. Zainuddin
{"title":"Relationship between TG/HDL-C Ratio and TyG Index with Chronic Inflammation in People with Prediabetes: A Cross-Sectional Study","authors":"Rizal Fahly, Fabiola M. S. Adam, H. Rasyid, A. Aman, S. Bakri, Idar Mappangara, A. A. Zainuddin","doi":"10.5603/dk.a2022.0047","DOIUrl":"https://doi.org/10.5603/dk.a2022.0047","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":"112 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74706484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Survey to Specify SGLT2 Inhibitor Choice in T2DM Management T2DM治疗中SGLT2抑制剂选择的调查
IF 0.7
Clinical Diabetology Pub Date : 2022-10-31 DOI: 10.5603/dk.a2022.0042
S. Ghosal, Radhika M. Joshi, Rahul N. Iyer, S. Adsule
{"title":"Survey to Specify SGLT2 Inhibitor Choice in T2DM Management","authors":"S. Ghosal, Radhika M. Joshi, Rahul N. Iyer, S. Adsule","doi":"10.5603/dk.a2022.0042","DOIUrl":"https://doi.org/10.5603/dk.a2022.0042","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":"26 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78460042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inpatient Mortality in People With Type 2 Diabetes: A Cross-sectional Study 2型糖尿病患者住院死亡率:一项横断面研究
IF 0.7
Clinical Diabetology Pub Date : 2022-10-31 DOI: 10.5603/dk.a2022.0049
Maria Cristina Carrondo, J. Moita
{"title":"Inpatient Mortality in People With Type 2 Diabetes: A Cross-sectional Study","authors":"Maria Cristina Carrondo, J. Moita","doi":"10.5603/dk.a2022.0049","DOIUrl":"https://doi.org/10.5603/dk.a2022.0049","url":null,"abstract":"Objective: This study aimed to estimate inpatient mortality rate for diabetes and identify its associated factors. Material(s) and Method(s): This is a cross-sectional study. The population was comprised between January 1 and December 31, 2019 in 32 public hospitals in Portugal, using summary hospital discharge data. We used both the Disease-Related Diagnosis Groups and the Disease Staging. Patients were grouped into survivors and non-survivors, and inpatient mortality was compared using competing event regression. Result(s): A total of 7980 patients were admitted with type 2 diabetes mellitus, there were 747 (10.3%) non-survivors. The advanced age (OR = 1.772;95% CI 1.625-1.932), the stage (3) severity of type 2 diabetes mellitus (OR = 4.301;95% CI 2.564-7.215), comorbid lung, bronchial or mediastinal malignant neoplasm (OR = 5.118;95% CI 2.222-11.788), comorbid bacterial pneumonia (OR = 3.214;95% CI 2.539-4.070), other respiratory system disorders (OR = 2.187;95%CI1.645-2.909),comorbidrhino-,adeno-andcorona-virus infections (OR = 1.680;95% CI 1.135-2.488) were determinants for inpatient mortality. Conclusion(s): Elderly patients with diabetes with micro- and macrovascular complications of the disease, who have bacterial pneumonia and who enter the emergency department are those who have a lower survival rate. Copyright © 2022 Via Medica. All rights reserved.","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":"24 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74792154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impaired Brain Insulin Signalling,a Potential Cause of Obesity: A Review of Literature 脑胰岛素信号受损,肥胖的潜在原因:文献综述
IF 0.7
Clinical Diabetology Pub Date : 2022-10-31 DOI: 10.5603/dk.a2022.0040
M. Bukowska
{"title":"Impaired Brain Insulin Signalling,a Potential Cause of Obesity: A Review of Literature","authors":"M. Bukowska","doi":"10.5603/dk.a2022.0040","DOIUrl":"https://doi.org/10.5603/dk.a2022.0040","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":"48 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89856650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardio-Renal Benefits of GLP-1 Receptor Agonists vs. SGLT-2 Inhibitors in Type 2 Diabetes: Are They Juxtaposed? GLP-1受体激动剂与SGLT-2抑制剂对2型糖尿病的心脏和肾脏益处:它们是并列的吗?
IF 0.7
Clinical Diabetology Pub Date : 2022-08-31 DOI: 10.5603/dk.a2022.0037
A. Singh, Viral N Shah
{"title":"Cardio-Renal Benefits of GLP-1 Receptor Agonists vs. SGLT-2 Inhibitors in Type 2 Diabetes: Are They Juxtaposed?","authors":"A. Singh, Viral N Shah","doi":"10.5603/dk.a2022.0037","DOIUrl":"https://doi.org/10.5603/dk.a2022.0037","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":"49 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85392748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between Newly Diagnosed Type 2 Diabetes Mellitus and Left Ventricular Global Longitudinal Strain: A Single Center, Cross-Sectional Study 新诊断的2型糖尿病与左心室整体纵向应变的关系:一项单中心横断面研究
IF 0.7
Clinical Diabetology Pub Date : 2022-08-31 DOI: 10.5603/dk.a2022.0029
V. Hyseni, S. Elezi, X. Krasniqi, Rozafa Olloni Nikaj, Vjollca Dedushaj Fazliu, Zana Vela Gaxha, A. Bakalli
{"title":"Association between Newly Diagnosed Type 2 Diabetes Mellitus and Left Ventricular Global Longitudinal Strain: A Single Center, Cross-Sectional Study","authors":"V. Hyseni, S. Elezi, X. Krasniqi, Rozafa Olloni Nikaj, Vjollca Dedushaj Fazliu, Zana Vela Gaxha, A. Bakalli","doi":"10.5603/dk.a2022.0029","DOIUrl":"https://doi.org/10.5603/dk.a2022.0029","url":null,"abstract":"Objective: Diabetes mellitus is a major cardiovascular risk factor. Diabetic complications in the cardiovascular system randomly appear following long standing diabetes. However, newly diagnosed diabetes can also be associated with cardiac problems. The aim of this study was to compare patients with newly diagnosed type 2 diabetes mellitus (T2DM) to healthy controls in regard to echocardiography features, specifically left ventricular global longitudinal strain (LV GLS). Materials and methods: This was a prospective cross-sectional study conducted on 94 patients, 52 patients with newly diagnosed T2DM that formed the first group and 42 healthy subjects, without history of diabetes mellitus and/or cardiovascular disease, which formed the second group. Results: Patients with newly diagnosed T2DM had mean glucose level of 16.37 ± 7.43 mmol/L and HbA1c of 8.57 ± 2.31 %. The groups did not differ in regard to age, gender, smoking, arterial hypertension or heart rate at the time of examination. The ratio between early mitral inflow velocity and mitral annu lar early diastolic velocity (E/e’) of the septal wall was significantly lower in patients with newly diagnosed T2DM (6.21 ± 3.14 vs. 7.8 ± 2.45, p = 0.009). The LV GLS resulted lower in patients with newly diagnosed T2DM compared to the healthy subjects (|–19.36|% ± 2.98 vs. |–20.43|% ± 1.99. p = 0.049). Of note, the LV GLS values are expressed as absolute numbers. The ratio of patients with LV GLS strain <|–18.8|% was significantly higher in patients with newly diagnosed T2DM (42.31% vs. 21.43%, p = 0.03). Conclusions: LV GLS may serve as an important echo cardiographic parameter to detect early myocardial changes in asymptomatic patients with newly diagnosed T2DM. (Clin Diabetol 2022, 11; 4: 245–250)","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":"187 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85457816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Renal Threshold for Glucose Re-Absorption in Patients with Latent Autoimmune Diabetes of Adults is Similar to That of Patients with Type 1 Diabetes Mellitus but Lower than That of Patients with Type 2 Diabetes Mellitus 成人潜伏性自身免疫性糖尿病患者的葡萄糖再吸收肾阈值与1型糖尿病患者相似,但低于2型糖尿病患者
IF 0.7
Clinical Diabetology Pub Date : 2022-08-31 DOI: 10.5603/dk.a2022.0035
S. Okada, K. Kikkawa, Junichi Okada, Kazuya Okada, Eijiro Yamada, Kihachi Ohshima
{"title":"Renal Threshold for Glucose Re-Absorption in Patients with Latent Autoimmune Diabetes of Adults is Similar to That of Patients with Type 1 Diabetes Mellitus but Lower than That of Patients with Type 2 Diabetes Mellitus","authors":"S. Okada, K. Kikkawa, Junichi Okada, Kazuya Okada, Eijiro Yamada, Kihachi Ohshima","doi":"10.5603/dk.a2022.0035","DOIUrl":"https://doi.org/10.5603/dk.a2022.0035","url":null,"abstract":"Address for correspondence: Shuichi Okada Department of Diabetes and Endocrinology, Hidaka Hospital 886 Nakao-machi Takasaki, Gunma 370-0001, Japan phone: +81-27-362-6201; fax: 81-27-362-0217 email: okadash1823@gmail.com Clinical Diabetology 2022, 11; 4: 296–297 DOI: 10.5603/DK.a2022.0035 Received: 5.07.2022 Accepted: 26.07.2022 Shuichi Okada1, Koji Kikkawa1, Junichi Okada2, Kazuya Okada3, Eijiro Yamada4, Kihachi Ohshima1 1Department of Diabetes and Endocrinology, Hidaka Hospital, Gunma, Japan 2Department of Medicine, Division of Endocrinology, Albert Einstein College of Medicine, New York, USA 3Omagari Kousei Medical Center, Akita, Japan 4Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Gunma, Japan","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":"1 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74705844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信